13620-31-0

Basic information

• Product Name: Acetonitrile, (phenylmethoxy)-
• CAS NO: 13620-31-0
• Molecular Formula: C9H9NO
• Molecular Weight: 147.177
• Mol File: 13620-31-0.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Acetonitrile, (phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetonitrile, (phenylmethoxy)-(13620-31-0)
• EPA Substance Registry System: Acetonitrile, (phenylmethoxy)-(13620-31-0)

Safety Data

• Hazardous Substances Data: 13620-31-0(Hazardous Substances Data)

Upstream product

• 32122-09-1 ethyl benzyloxyacetate 
• 100-51-6 benzyl alcohol 
• 590-17-0 cyanomethyl bromide 
• 50-00-0 formaldehyd 
• 151-50-8 potassium cyanide 
• 100-44-7 benzyl chloride 
• 143-33-9 sodium cyanide 
• 60656-87-3 benzyloxyacetoaldehyde 
• 5774-77-6 2-(benzyloxy)acetamide 

Downstream Products

• 141376-54-7 2-(benzyloxy)-1-<3-(benzyloxy)phenyl>ethanone 
• 118599-78-3 2,4(5)-bis<(benzyloxy)methyl>-2-imidazoline 
• 1428548-40-6 ethyl 2-((benzyloxy)methyl)-4-hydroxypyrimidine-5-carboxylate 
• 1428548-41-7 2-((benzyloxy)methyl)-4-hydroxypyrimidine-5-carboxylic acid 
• 1428548-42-8 N-benzhydryl-2-((benzyloxy)methyl)-4-hydroxypyrimidine-5-carboxamide 
• 1428548-47-3 2-[(benzyloxy)methyl]-N-[bis(4-methoxyphenyl)methyl]-4-hydroxypyrimidine-5-carboxamide 
• 1428548-52-0 2-[(benzyloxy)methyl]-N-[bis(4-fluorophenyl)methyl]-4-hydroxypyrimidine-5-carboxamide 
• 1428548-56-4 2-((benzyloxy)methyl)-4-hydroxy-N-(naphthalen-1-ylmethyl)pyrimidine-5-carboxamide 
• 1428548-60-0 2-((benzyloxy)methyl)-4-hydroxy-N-(naphthalen-2-ylmethyl)pyrimidine-5-carboxamide 
• 636559-67-6 C₇₀H₇₂O₇Si₃ 
• 1178791-69-9 C₁₃H₂₁NO 
• 265664-91-3 1-(2-phenylmethoxy)-2-butanone 

Relevant articles and documents

AMINOPYRIMIDINE COMPOUND USED FOR INHIBITING ACTIVITY OF PROTEIN KINASE

The present invention relates to an aminopyrimidine compound having an inhibitory effect on the activity of protein kinase as well as the preparation and use thereof. Specifically, disclosed by the present invention is an aminopyrimidine compound represented by formula (I), or a pharmaceutically acceptable salt, stereoisomer, solvate or hydrate thereof, as well as a pharmaceutical composition comprising said compound and a use method therefor. The method comprises a method for treating cell proliferative diseases and conditions such as cancer and immune diseases.

Direct Synthesis of Nitriles from Aldehydes Using an O-Benzoyl Hydroxylamine (BHA) as the Nitrogen Source

The direct synthesis of nitriles from commercially available or easily prepared aldehydes has been achieved. O-(4-CF3-benzoyl)-hydroxylamine (CF3-BHA) was utilized as the nitrogen source to generate O-acyl oximes in situ with aldehydes, which can be converted to a nitrile with the assistance of a Bronsted acid. Several aliphatic, aromatic, and α,β-unsaturated nitriles that contain different functional groups were prepared in high yields (up to 94% yield). This method has notable advantages, such as simple and mild conditions, high yields, and good functional group tolerance.

SUBSTITUTED PYRIMIDINES

The present invention relates to substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.